10x Genomics (TXG) Receives a Buy from Morgan Stanley
Morgan Stanley analyst Tejas Savant maintained a Buy rating on 10x Genomics (TXG – Research Report) today and set a price target of $26.00. The ...
News Medical1d
Leveling up NGS workflows with INTEGRA Biosciences’ solutions
INTEGRA Biosciences offers liquid handling solutions and magnetic modules to streamline every stage of NGS sample preparation ...
Companion Diagnostics Market Trends 2019-2024 and Forecast to 2034 - Rising Number of Targeted Therapies Driving the $8.75 Billion Industry
Companion Diagnostics Market Companion Diagnostics Market Dublin, Feb. 13, 2025 (GLOBE NEWSWIRE) -- The "Companion ...
pratt.duke2d
Activating Complex Regions of the Genome to Treat Rare Diseases
Researchers find a master epigenetic switch that activates silenced genes to compensate for their missing counterparts in a ...
Genomic Data Analysis and Interpretation Market Research 2025-2033: Syngenta Group Leads, Followed by Amgen, Monsanto (Bayer), and Illumina
The "Genomic Data Analysis and Interpretation Market Opportunities and Strategies to 2033" report has been added to ...
News Medical6d
Distinct myeloid-derived suppressor cell populations fuel aggressive brain tumor growth
A type of aggressive, treatment-resistant brain tumor has a distinct population of immune cells that support its growth, according to new research led by investigators at the Johns Hopkins Kimmel ...